No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
IOVA Iovance Biotherapeutics
- 11.320
- +0.010+0.09%
Close Apr 22 16:00 ET
- 11.300
- -0.020-0.18%
Post 19:54 ET
3.16BMarket Cap-5989P/E (TTM)
11.635High11.070Low2.40MVolume11.540Open11.310Pre Close27.29MTurnover1.14%Turnover RatioLossP/E (Static)279.31MShares18.33052wk High5.41P/B2.39BFloat Cap3.21052wk Low--Dividend TTM210.90MShs Float165.000Historical High--Div YieldTTM5.00%Amplitude1.000Historical Low11.346Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
AHN Cancer Institute To Offer Groundbreaking Treatment For Metastatic Melanoma; The One-Time Treatment, Made By Iovance Biotherapeutics, Is The First FDA-Approved T-Cell Therapy For Solid Tumors
Allegheny Health Network (AHN) Cancer Institute has become the first health care system in Western Pennsylvania to offer a first-of-its-kind cellular therapy recently approved by the U.S. Food and Dru
Exelixis Slips as Barclays Downgrades on Lack of Catalysts
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
Better Growth Biotech Buy: Iovance Biotherapeutics Vs CRISPR Therapeutics
Iovance Biotherapeutics (IOVA) Down 6.9% Since Last Earnings Report: Can It Rebound?
Comments
Updated Complete & Utter M&A Guesses Purely for Entertainment Purposes:
$SPDR S&P Biotech ETF(XBI.US$
$Merck & Co(MRK.US$ x $Immunovant(IMVT.US$
$Eli Lilly and Co(LLY.US$ x $Cytokinetics(CYTK.US$ (and soon)
$Regeneron Pharmaceuticals(REGN.US$ x $Apellis Pharmaceuticals(APLS.US$ (panache & brash)
$Gilead Sciences(GILD.US$ x %$Madrigal Pharmaceuticals(MDGL.US$ (liver king)
$Bristol-Myers Squibb(BMY.US$ x $Iovance Biotherapeutics(IOVA.US$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US$ x $Merus(MRUS.US$ (partner n...
$Merck & Co(MRK.US$ x $Immunovant(IMVT.US$
$Eli Lilly and Co(LLY.US$ x $Cytokinetics(CYTK.US$ (and soon)
$Regeneron Pharmaceuticals(REGN.US$ x $Apellis Pharmaceuticals(APLS.US$ (panache & brash)
$Gilead Sciences(GILD.US$ x %$Madrigal Pharmaceuticals(MDGL.US$ (liver king)
$Bristol-Myers Squibb(BMY.US$ x $Iovance Biotherapeutics(IOVA.US$ (cell Tx boost needed)
$Eli Lilly and Co(LLY.US$ x $Merus(MRUS.US$ (partner n...
2
Update
$Iovance Biotherapeutics(IOVA.US$ Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
4 MINUTES AGO, 6:30 AM EST
VIA GLOBENEWSWIRE
4 MINUTES AGO, 6:30 AM EST
VIA GLOBENEWSWIRE
4
3
Grateful with whatever the gain though
hhh, reenter.. I should have stopped daytrade better swing for biotech, easier to get gain if got FDA approval...
$Biotechnology(BK2069.US$
$Iovance Biotherapeutics(IOVA.US$
$Biotechnology(BK2069.US$
$Iovance Biotherapeutics(IOVA.US$
2
$Iovance Biotherapeutics(IOVA.US$ well that was scary
2
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg